Morgan Stanley En V Veno Medical Corp Transaction History

Morgan Stanley

$1.36 Trillion
Q1 2025

A detailed history of Morgan Stanley transactions in En V Veno Medical Corp stock. As of the latest transaction made, Morgan Stanley holds 65,964 shares of NVNO stock, worth $225,596. This represents 0.0% of its overall portfolio holdings.

Number of Shares

65,964

Previous 126,932 48.03%

Holding current value

$225,596

Previous $374,000 53.74%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$2.63 - $3.77 $160,345 - $229,849	-60,968 Reduced 48.03%	65,964 $173,000
Q4 2024 Feb 14, 2025	SELL	$2.49 - $3.65 $17,928 - $26,280	-7,200 Reduced 5.37%	126,932 $374,000
Q3 2024 May 14, 2025	BUY	$3.24 - $6.19 $127,199 - $243,013	39,259 Added 41.38%	134,132 $450,000
Q3 2024 Nov 14, 2024	BUY	$3.24 - $6.19 $127,199 - $243,013	39,259 Added 41.38%	134,132 $450,000
Q2 2024 May 14, 2025	SELL	$4.62 - $5.5 $148,112 - $176,324	-32,059 Reduced 25.26%	94,873 $498,000
Q2 2024 Oct 17, 2024	SELL	$4.62 - $5.5 $12,367 - $14,723	-2,677 Reduced 2.74%	94,873 $498,000
Q2 2024 Aug 14, 2024	SELL	$4.62 - $5.5 $12,367 - $14,723	-2,677 Reduced 2.74%	94,873 $498,000
Q1 2024 Oct 17, 2024	BUY	$3.94 - $6.65 $10,547 - $17,802	2,677 Added 2.82%	97,550 $530,000
Q1 2024 Aug 16, 2024	BUY	$3.94 - $6.65 $145,799 - $246,083	37,005 Added 61.12%	97,550 $530,000
Q1 2024 May 15, 2024	BUY	$3.94 - $6.65 $145,799 - $246,083	37,005 Added 61.12%	97,550 $530,000
Q4 2023 Aug 16, 2024	SELL	$3.46 - $5.73 $118,774 - $196,699	-34,328 Reduced 36.18%	60,545 $311,000
Q4 2023 Feb 13, 2024	BUY	$3.46 - $5.73 $59,619 - $98,733	17,231 Added 39.78%	60,545 $311,000
Q3 2023 Nov 15, 2023	BUY	$3.16 - $5.74 $19,996 - $36,322	6,328 Added 17.11%	43,314 $233,000
Q2 2023 Aug 14, 2023	BUY	$2.6 - $5.19 $21,013 - $41,945	8,082 Added 27.96%	36,986 $113,000
Q1 2023 May 15, 2023	SELL	$4.66 - $6.3 $7,111 - $9,613	-1,526 Reduced 5.01%	28,904 $135,000
Q4 2022 Feb 14, 2023	SELL	$4.54 - $6.6 $8,421 - $12,243	-1,855 Reduced 5.75%	30,430 $155,000
Q3 2022 Nov 14, 2022	BUY	$0.1 - $7.82 $400 - $31,319	4,005 Added 14.16%	32,285 $203,000
Q2 2022 Oct 27, 2022	SELL	$3.39 - $6.5 $26,014 - $49,881	-7,674 Reduced 21.34%	28,280 $107,000
Q2 2022 Aug 15, 2022	SELL	$3.39 - $6.5 $26,014 - $49,881	-7,674 Reduced 21.34%	28,280 $107,000
Q1 2022 Oct 27, 2022	BUY	$4.42 - $7.0 $33,919 - $53,718	7,674 Added 27.14%	35,954 $230,000
Q1 2022 May 13, 2022	SELL	$4.42 - $7.0 $91,829 - $145,432	-20,776 Reduced 36.62%	35,954 $230,000
Q4 2021 Feb 14, 2022	BUY	$6.23 - $10.24 $353,427 - $580,915	56,730 New	56,730 $374,000

Others Institutions Holding NVNO

# of Institutions

Shares Held

4.05M

Call Options Held

34.1K

Put Options Held

2.5K

View Full List

About enVVeno Medical Corp

Ticker NVNO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 9,469,850
Market Cap $32.4M
Description
enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency...

More about NVNO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account